US 7303746
Methods of treating eye disorders with modified chimeric polypeptides
granted A61KA61K38/00
Quick answer
US patent 7303746 (Methods of treating eye disorders with modified chimeric polypeptides) held by REGENERON PHARMACEUTICALS, INC. expires Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Dec 04 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 29 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 5
- CPC classes
- A61K, A61K38/00